Clin Lipidology. 2009;4(5):565-571. Given this information, there remains a key question: will ERN's ability to change LDL-P result in a measurably favorable change in cardiovascular outcomes?
Niacin has long been used as an effective lipid-altering therapy, particularly for raising HDL-C and lowering triglyceride levels. In addition, niacin modestly lowers LDL-C levels. LDL-C ...
Small quantities are found in the meat and dairy of ruminant (grass-eating) animals, including cows. Artificial trans fats are commonly found in highly processed, fried, and packaged foods. Trans fats ...
The markers or instruments for LDL-C were obtained from the Global Lipid Genetics Consortium. Genetic associations for stroke and subtypes were obtained from the GIGASTROKE Consortium. These markers ...
Background: The triglyceride (TG) content of low-density lipoprotein (LDL-TG) has been shown to be more predictive of atherosclerotic cardiovascular disease (ASCVD) events than the cholesterol content ...